Research programme: Alzheimer's disease therapeutics - Therasid Bioscience
Latest Information Update: 01 Oct 2021
At a glance
- Originator Therasid Bioscience
- Class Antidementias
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Alzheimer's disease
Most Recent Events
- 28 Sep 2021 Early research in Alzheimer's disease in South Korea (unspecified route) (Therasid Bioscience pipeline, September 2021)